Patents by Inventor Maria Empar CHENOLL CUADROS

Maria Empar CHENOLL CUADROS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230048705
    Abstract: The present invention is intended for the use of a probiotic composition comprising Bifidobacterium animalis subs. lactis (B. lactis), Bifidobacterium longum and Lactobacillus casei, particularly the strains B. lactis CECT 8145, B. longum CECT 7347 and/or L. casei CECT 9104, in the treatment and/or prevention of atopic dermatitis.
    Type: Application
    Filed: August 15, 2022
    Publication date: February 16, 2023
    Inventors: Vicente Manuel NAVARRO LÓPEZ, Ana Adela RAMÍREZ BOSCÁ, José Manuel PÉREZ ORQUÍN, Daniel RAMÓN VIDAL, Salvador GENOVÉS MARTÍNEZ, María Empar CHENOLL CUADROS, Francisco Manuel CODOÑER CORTÉS
  • Publication number: 20230028548
    Abstract: This invention refers to a probiotic composition consisting of the bacteria Lactobacillus rhamnosus, Lactobacillus casei and Bifidobacterium longum, preferably of the strains L. rhamnosus CECT8361, L. casei CECT9104 and B. longum CECT7347, and its use as an antioxidant. This composition is particularly useful in the treatment and/or prevention of damage, at the molecular level, caused by oxidative stress, preferably during high intensity physical exercise.
    Type: Application
    Filed: January 14, 2021
    Publication date: January 26, 2023
    Inventors: Maria Empar CHENOLL CUADROS, Patricia MARTORELL GUEROLA, Salvador GENOVÉS MARTÍNEZ, Daniel RAMÓN VIDAL, Francisco Javier LÓPEZ ROMÁN, Vincente ÁVILA GANDÍA, Fernando CÁNOVAS GARCÍA
  • Patent number: 11202813
    Abstract: A novel lactic acid Lactobacillus rhamnosus bacterium suitable for treatment of e.g. bacterial vaginosis.
    Type: Grant
    Filed: March 3, 2020
    Date of Patent: December 21, 2021
    Assignee: FERRING B.V.
    Inventors: Maria Empar Chenoll Cuadros, Beatriz Casinos Ramo, Angela Silva Angulo, Daniel Ramon Vidal, Salvador Genoves Martinez
  • Patent number: 10912802
    Abstract: The present invention is intended for the use of a probiotic composition comprising Bifidobacterium animalis subs. lactis (B. lactis), Bifidobacterium longum and Lactobacillus rhamnosus, in particular the strains B. lactis CECT 8145, B. longum ES1 CECT 7347 and/or L. rhamnosus CECT 8361, in the treatment and/or prevention of psoriasis outbreaks or psoriasis.
    Type: Grant
    Filed: March 21, 2017
    Date of Patent: February 9, 2021
    Assignees: Bionou Research, S.L., KOROTT, S.L., BIOPOLIS, S.L.
    Inventors: Vicente Manuel Navarro López, Ana Adela Ramírez Boscá, José Manuel Pérez Orquín, Daniel Ramón Vidal, Salvador Genovés Martínez, María Empar Chenoll Cuadros, Francisco Manuel Codoñer Cortés
  • Publication number: 20200268815
    Abstract: A novel lactic acid Lactobacillus rhamnosus bacterium suitable for treatment of e.g. bacterial vaginosis.
    Type: Application
    Filed: March 3, 2020
    Publication date: August 27, 2020
    Applicant: Ferring B.V.
    Inventors: Maria Empar CHENOLL CUADROS, Beatriz CASINOS RAMO, Angela SILVA ANGULO, Daniel RAMON VIDAL, Salvador GENOVES MARTINEZ
  • Patent number: 10588926
    Abstract: A novel lactic acid Lactobacillus rhamnosus bacterium suitable for treatment of e.g. bacterial vaginosis.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: March 17, 2020
    Assignee: FERRING B.V.
    Inventors: Maria Empar Chenoll Cuadros, Beatriz Casinos Ramo, Angela Silva Angulo, Daniel Ramon Vidal, Salvador Genoves Martinez
  • Publication number: 20190328799
    Abstract: The present invention is intended for the use of a probiotic composition comprising Bifidobacterium animalis subs. lactis (B. lactis), Bifidobacterium longum and Lactobacillus rhamnosus, in particular the strains B. lactis CECT 8145, B. longum ES1 CECT 7347 and/or L. rhamnosus CECT 8361, in the treatment and/or prevention of psoriasis outbreaks or psoriasis.
    Type: Application
    Filed: March 21, 2017
    Publication date: October 31, 2019
    Inventors: Vicente Manuel NAVARRO LÓPEZ, Ana Adela RAMÍREZ BOSCÁ, José Manuel PÉREZ ORQUÍN, Daniel RAMÓN VIDAL, Salvador GENOVÉS MARTÍNEZ, MarÍa Empar CHENOLL CUADROS, Francisco CODOÑER CORTÉS
  • Publication number: 20190282636
    Abstract: The present invention is intended for the use of a probiotic composition comprising Bifidobacterium animalis subs. lactis (B. lactis), Bifidobacterium longum and Lactobacillus casei, particularly the strains B. lactis CECT 8145, B. longum CECT 7347 and/or L. casei CECT 9104, in the treatment and/or prevention of atopic dermatitis.
    Type: Application
    Filed: July 18, 2017
    Publication date: September 19, 2019
    Inventors: Vicente Manuel NAVARRO LÓPEZ, Ana Adela RAMÍREZ BOSCÁ, José Manuel PÉREZ ORQUÍN, Daniel RAMÓN VIDAL, Salvador GENOVÉS MARTÍNEZ, Maria Empar CHENOLL CUADROS, Francisco Manuel CODOÑER CORTÉS
  • Publication number: 20180228850
    Abstract: A novel lactic acid Lactobacillus rhamnosus bacterium suitable for treatment of e.g. bacterial vaginosis.
    Type: Application
    Filed: June 29, 2016
    Publication date: August 16, 2018
    Applicant: FERRING B.V.
    Inventors: Maria Empar CHENOLL CUADROS, Beatriz CASINOS RAMO, Angela SILVA ANGULO, Daniel RAMON VIDAL, Salvador GENOVES MARTINEZ